Corporate finance business Marechale Capital (LON: MAC) has obtained FCA approval for the acquisition of Stanford Capital Partners. This is one of the three acquisitions announced the previous week that will scale up the business. The share price increased a further 56.2% to 6.95p and it is 248% higher over two weeks.

Medpal AI (LON: MPAL) says that the UK regulatory approval of the first oral GLP-1 receptor agonist tablet developed by Novo Nordisk has come earlier than expected and this will provide a boost for the company’s New Health weight management clinic. It broadens the potential market. The share price gained 50.9% to 4.15p.

Mindflair (LON: MFAI) says CameraMatics, an investee company of Sure Valley Ventures, is raising up to €49m and Sure Valley Ventures first fund is realising part of its investment. This means that Mindflair, which invests in the fund, will receive a share of €280,000 in cash and will have a €320,000 working capital facility repaid. It also owns 24.4% of Sure Ventures plc which will receive €880,000. The share price rose 29.4% to 0.55p.

Altitude Group (LON: ALT) director Martin Varley bought 180,222 shares at 19p each and 26,124 shares at 21.8p each. He owns 13.8% of the promotional products services provider. The share price improved 23.7% to 23.5p.

FALLERS

Marketing services provider Silver Bullet Data Services (LON: SBDS) is asking for shareholder approval for a departure from AIM. It argues that the weak financial markets mean that the company is undervalued and hampers its ability to raise money. This will also save £500,000 each year. A general meeting will be held on 25 June. A matched bargains facility operated by JP Jenkins will operate for at least 12 months. The company joined AIM on 28 June when it was valued at £34.5m at the placing price of 257p. The share price slumped 67.9% to 8.5p.

Shares in Pri0R1Ty Intelligence (LON: PR1) slid 48.5% to 0.875p when they returned from suspension. The AI software business generated revenues of £174,000 in the year to September 2025 and the underlying loss was £3.3m. Cash was £796,000 at the end of September 2025. So far this year contracted revenues are more than £400,000. Prior to the results announcement the company announced an unsecured convertible loan note of £1.25m, and an At-The-Market facility will enable repayment of the convertible through share issues. The cash will provide working capital.

Ascent Resources (LON: AST) admitted that its 2025 results would not be published before the end of June. This is due to the consolidation of US acquisitions. Trading in the shares will be suspended on 1 July. Funding options are being assessed. The share price declined 30% to 0.35p.

Atome Energy (LON: ATOM) says that a presidential decree relating to the fixed price power purchase agreement with ANDE in Paraguay has been revoked. This means that there is uncertainty about the electricity tariffs for the Viletta fertiliser production project. The share price fell 29.1% to 39p.

The FTSE 100 jumped on Friday after the US President claimed a deal with Iran that would see the opening of the Strait of Hormuz could be struck as soon as this weekend.

Iran, however, said nothing had been finalised.

We’ve been here before on a number occasions so although the market reaction was positive, it fell short of the euphoric surge in stocks we’ve experienced in the past.

The FTSE 100 was trading 1.1% higher at the time of writing, but still within the trading range it has resided since Trump first announced a ceasefire in April.

“Investors were in a buoyant mood as hopes of a peace deal between the US and Iran were revived, having seemingly dropped off the table earlier in the week,” said Dan Coatsworth, head of markets at AJ Bell.

“The maxim ‘once bitten, twice shy,’ isn’t being applied by the market when it comes to Donald Trump’s pronouncements, as his latest of several suggestions a deal is close has helped to drive stocks higher once more. 

 “Oil is heading in the opposite direction, with the Brent crude benchmark dropping and sticking below $90 per barrel for only the third time since the Middle East conflict began.”

Away from the  Middle East, attention today will be firmly on SpaceX after the company raised $75bn in the largest IPO the world has ever seen. Elon Musk is set to become the world’s first trillionaire as shares start trading, but it’s not just Elon Musk’s fortunes that will be impacted by the IPO.

There are mixed views on the IPO with some analysts calling for a much higher valuation while some believe IPO investors have overpaid.

Whichever way the SpaceX share price goes in the coming weeks, it will likely have an impact on sentiment and equity market performance.

In London, airlines reacted well to falling oil prices with IAG leaping 6% higher to the top of the leaderboard.

A deal between the US and Iran would also mean the aversion of damaging inflation and interest rate cuts. This helped Housebuilders higher.

Oil stocks were the inevitable losers with a proposed deal to open the Strait of Hormuz in sight.

BP and Shell were both down over 3% and were at the bottom of the leaderboard.

Medpal AI (LON: MPAL) says that the UK regulatory approval of the first oral GLP-1 receptor agonist tablet developed by Novo Nordisk has come earlier than expected and this will provide a boost for the company’s New Health weight management clinic. It broadens the potential market. The share price jumped 19.35% to 3.7p.

Pennant International (LON: PEN) has won another contract for its Auxilium software. It is a multi-year framework agreement with the Canadian Department of National Defence for integrated product support services. This replaces shorter-term contracts. It is estimated that the contract could be worth £1.6m each year, which is more than 10% of forecast 2027 revenues. The share price rebounded 10.6% to 26p.

Camellia (LON: CAM) has sold a substantial amount of its remaining South Asian art collection via auction for £14m after costs. Gross profit is £13.4m. The share price gained 4.21% to £55.75.

Hutchmed China Ltd (LON: HCM) has presented Sovleplenib ESLIM-2 phase III data in warm antibody autoimmune haemolytic anaemia in China. The study met its primary endpoint with a much higher reaction than to the placebo. The share price rose 3.4% to 175p.

FALLERS

Shares in Pri0R1Ty Intelligence (LON: PR1) halved to 0.85p when they returned from suspension. The AI software business generated revenues of £174,000 in the year to September 2025 and the underlying loss was £3.3m. Cash was £796,000 at the end of September 2025. More cash is required. So far this year contracted revenues are more than £400,000.

Virgin Wines (LON: VINO) says full year revenues are 4% ahead even though the wine retail market is down by one-fifth. The fourth quarter was slightly weaker than expected. Higher rent costs and lower interest income have led to an increase in forecast 2025-26 loss to £1.5m. Warehousing is being consolidated in Preston. Cavendish expects a lower loss in 2026-27 and forecast net cash of £4m at the end of June 2027 should be the low point. The share price declined 14.9% to 28.5p.

Aquis-quoted energy B (NRGB) is acquiring the 35% working interest in the Horse Hill oil field near Gatwick owned by UK Oil and Gas (UKOG), as well as the 77.9% shareholding in Horse Hill Developments. The combined interest in the relevant licences is 85.6%. The payment is £1m with an initial deposit of £100,000. The cash will be invested in UK salt cavern energy storage projects and other opportunities. The UKOG share price fell 10.3% to 0.00875p.

Fuel ingredients development Quadrise (LON: QED) reveals that there is a delay to the Valkor oil sands pilot plant until the end of 2026, when it was previously expected by the end of June. This means that the $950,000 licence fee should be received by the end of September, assuming project funding is agreed. The share price slipped 5.66% to 1.7925p.

Quadrise has given investors a mixed update on its Utah project with Valkor Technologies, confirming progress towards deployment but also pushing back several key milestones.

The AIM-listed decarbonisation specialist, which is developing low-emission fuels for shipping and heavy industry, said work continues towards pilot deployment and commercial demonstration of its upstream production model. Its equipment is ready to go, and Quadrise has been told that heavy sweet oil samples have been prepared at Valkor’s new pilot plant ahead of formulating its MSAR and bioMSAR fuels.

It’s been a long road for Quadrise and its shareholders which has just become a little longer.

Valkor’s 500 barrel-per-day oil-sands pilot plant is now due to be commissioned in the fourth quarter of 2026. As a knock-on, Quadrise will no longer deliver its 600 bpd Multifuel Manufacturing Unit to site by the end of June as previously flagged. This is now thought to happen in the third quarter.

There’s also payments due that have been delayed. Of the $1.0m licence fee owed by Valkor, $0.95m remains unpaid as the partner waits on approved project funding. The board now expects to receive the fee in full by the end of September.

Investors weren’t over the moon and shares slipped 9% on Friday.

TruFin is returning £80m to shareholders following the sale of its games business Playstack, the company has confirmed.

The AIM-listed group previously sold its 84.5% interest in Playstack to VantageCo, an indirect subsidiary of the Integrated Media Company group, in a deal valuing the business at an enterprise value of £125m on a debt-free, cash-free basis.

With the cash now available, the board has announced a two-part structure for the payout. First comes a tender offer, inviting shareholders to sell up to roughly £56.8m of stock back to the company at a fixed 140p a share. That will be followed by a compulsory special dividend of at least £23.2m, paid pro rata to those still on the register.

If the tender offer isn’t fully taken up, the special dividend will simply be topped up so the total returned still hits £80m.

TruFin has original planned to return £70m to shareholders when the deal was first announced.

Shares in the group were 2% higher on Friday.

Embedded computing products supplier Concurrent Technologies (LON: CNC) has won a four-year order worth £17m with a European defence contractor. This is three times the previous largest order. It is for ground based air defence systems and there is an upfront payment for the procurement of components that are due to stop production. Defence demand is strong and systems orders for this year so far are higher than for the whole of 2025. The share price increased 6.57% to 267.5p.

Ian Amiee, Daryl Amiee and Doolittle SSAS account Amiee has acquired a 3.06% stake in genetic tests developer GENinCode (LON: GENI). The share price recovered 8.33% to 0.975p.

Alaska-focused oil and gas explorer Pantheon Resources (LON: PANR) non-exec David Wilkins bought an initial 2.248 million shares at 15.7p/share. The share price is 6.84% higher at 16.645p.

Strategic communications company Aeorema Communications (LON: AEO) has been awarded a three-year contract for Climate Week NYC up until 2028. This takes place in September. The share price improved 4.8% to 65.5p.

Graphene company Haydale (LON: HAYD) has been expanded its agreement between Lloyds Banking Group and Haydale’s SaveMoneyCutCarbon platform. The initial pilot is being extended. Services are provided to smaller and medium-sized corporate clients of the bank. This will help to underpin current year forecast revenues of £8m. The share price rose 4.62% to 0.34p.

Titanium explorer Empire Metals (LON: EEE) says that there is potential to produce alumina as part of its potential production of tantalum at the Pitfield project. The company aims to produce titanium sponge for the titanium metal industry. An updated mineral resource estimate is expected by the end of August. Detailed engineering studies should be completed by the end of the year. The share price gained 4.77% to 34.575p.

FALLERS

Localisation, content and IP protection services provider RWS Holdings (LON: RWS) reported a recovery in interim revenues and profit, although current exchange rates are a headwind to further progress. There are 60% of revenues in US$ and the majority of costs are in Euros. In the six months to March 2026, revenues improved 5% to £360m, while an improved gross margins meant that underlying pre-tax profit was one-third higher at £24m. The dividend has been rebased and cut 29% to 1.75p/share. Net debt was £32.5m at the end of March 2026. Full year pre-tax profit is forecast to be around 10% ahead at £66m, which is still well below the 2023-24 level. The figure is held back by an initial loss from the recently acquired AI platform Obviously and the forex headwind. A 16.6% fall in the share price to 85.65p seems to be based on uncertainty about the second half, but trading is in line with expectations.

Wishbone Gold (LON: WSBN) has completed 14 holes of the 25 hole drilling programme at the Red Setter project in Western Australia. Samples are being sent to Perth and results are expected at the end of July. The share price declined 4.04% to 23.75p.

Ex-dividends

Cerillion (LON: CER) is paying an interim dividend of 5.5p/share and the share price recovered 10p to £12.20.

Christie Group (LON: CTG) is paying a final dividend of 2.75p/share and the share price fell 3.5p to 141.5p.

Impax Asset Management (LON: IPX) is paying an interim dividend of 2p/share and the share price rose 0.1p to 98.5p.

Judges Scientific (LON: JDG) is paying a final dividend of 82.3p/share and the share price increased 25p to £45.05.

London Security (LON: LSC) is paying a final dividend of 42p/share and the share price is unchanged at £34.

Restore (LON: RST) is paying a final dividend of 4.7p/share and the share price slipped 5.5p to 247.5p.

Warpaint London (LON: W7L) is paying a final dividend of 9p/share and the share price declined 8p to 210p.